Can Proteomics Transform Cancer Prevention? Learn from Dr. Stefánsson at PMWC Feb 5-7 – Healthcare Professional
Can we predict and prevent cancer before it strikes? Dr. Kári Stefánsson, founder of deCODE Genetics, is leading the way.
Interview Questions for Dan Chen, MD, PhD, Genesis Biocapital
1. With your extensive background at Genentech and foundational contributions to the Cancer-Immunity Cycle, can you share some insights on the key challenges and breakthroughs in cancer immunotherapy over the past decade, and how these have influenced the development of new therapies?
Cancer Fragmentation, Multi-Cancer Detection & Liquid Biopsy Innovation with Victor Velculescu & Nicola Aceto at PMWC 2025!
Dr. Victor Velculescu’s work with DELFI technology exemplifies these advancements. Using AI to analyze genome-wide cell-free DNA fragmentation, DELFI offers a breakthrough in early cancer detection. “This new machine-learning fragmentome approach provides a sensitive and accessible next-generation liquid biopsy method,” he explains, highlighting the importance of collaboration to bring these technologies into real-world clinical settings and improve patient outcomes.
NIH’s $110M Women’s Health Investment – Join PMWC 2025’s Women’s Health Track
Have you heard about the Historic $110M NIH Investment in Women’s Health? Following the NIH’s announcement of this ARPA-H funding, the PMWC 2025 Silicon Valley (Feb 5-7 Program) Women’s Health Track is primed to spotlight innovations that align with this transformative support.
The Dawn of Digital Biology: Jensen Huang’s (NVIDIA) Vision for AI in Healthcare at PMWC25
In a world where technology and healthcare converge, the visionary leadership of Jensen Huang, the CEO of NVIDIA is pioneering a revolution that could redefine our approach to medicine and biology. We are thrilled to announce that Jensen Huang will be the Luminary honoree at the PMWC 2025 Silicon Valley track on AI and Data Science in Research and Development in Track 2 on February 7th (View the full February 5-7 Silicon Valley Program).
Pioneering Minds Unite: Crystal Mackall, Drew Weissman, David R. Liu, Ira Mellman at PMWC25 CGT Oncology Track
We are thrilled to invite you to the Cell and Gene Therapy in Oncology Track at the upcoming Precision Medicine World Conference (PMWC) 2025 Silicon Valley – Feb 5-7. This track offers a unique opportunity to witness pioneering research and collaborative efforts that are reshaping the landscape of cancer treatment through innovative cell and gene therapies.
Join CDC & KOLs on Mpox, H5N1, & more at PMWC25!
Amid growing global concerns over infectious disease outbreaks like Mpox, the urgency for cutting-edge diagnostic and therapeutic innovations has never been greater. Join us at PMWC 2025, where world-renowned experts will share the latest advancements in precision diagnostics and public health solutions.
Interview Questions for Dr. Collen Masimirembwa
Your work has led to the discovery of significant genetic variants in the CYP2D6 and CYP2C19 genes among African populations, which are crucial for drug metabolism. This research has enabled the development of pharmacogenetic tests that tailor drug treatments to individual genetic profiles, significantly…
PGx Pioneers: Join Collen Masimirembwa, Russ Altman, Deepak Voora, and More at PMWC 2025
We are honored to invite you to an enlightening full-day track on pharmacogenomics at the upcoming PMWC 2025 Silicon Valley – February 5-7, 2025.
Exclusive PMWC Interview: Gene Therapy Pioneer Dr. James Wilson on Its Future
We are honored to announce Dr. James M. Wilson, a pioneer in gene therapy, as our distinguished Pioneer Honoree at PMWC February 5-7, 2025 Silicon Valley, where we will spotlight the transformative effect of cell and gene therapies in addressing complex medical challenges.
